Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BGLC compared with DGX: revenue, margins and what each company keeps, and the suppliers and customers both name
BGLC
BioNexus Gene Lab Corp
Change
Mkt cap
Revenue
Revenue
DGX
Quest Diagnostics Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
BGLC
BioNexus Gene Lab Corp
vs
DGX
Quest Diagnostics Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
BGLC: latest quarter is a loss; flow not drawable.
Method
›
BGLC
BioNexus Gene Lab Corp
Change
0.95
▼
−5.43%
Mkt cap
$2.8M
Revenue
$76,156
Q2 FY26
Revenue
$7M
FY25
DGX
Quest Diagnostics Inc
Change
254.15
▲
+2.87%
Regular session
Nov 4 '26
Mkt cap
$27.2B
Revenue
$3.1B
Q3 FY26
Revenue
$11.0B
FY25
vs
Compare
Regular session
Nov 4 '26
BGLC
BioNexus Gene Lab Corp
vs
DGX
Quest Diagnostics Inc
0.95
▼
−5.43%
Price
254.15
▲
+2.87%
$2.8M
Mkt cap
$27.2B
Q2 FY26
$76,156
Revenue
$3.1B
Q3 FY26
FY25
$7M
Revenue
$11.0B
FY25
Change
Change
BGLC
0.95
▼
−5.43%
vs
DGX
254.15
▲
+2.87%
Regular session
Nov 4 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BGLC
0
None
Shared
0
No disclosed counterparties: BGLC.
Only DGX
1
GRAL
Grail
customer
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BGLC, solid
DGX, dashed